ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Identification of a Recurrence Gene Signature for Ovarian Cancer Prognosis by Integrating Single-Cell RNA Sequencing and Bulk Expression Datasets

Zhang, Yongjian; Huang, Wei; Chen, Dejia; Zhao, Yue; Sun, Fusheng; Wang, Zhiqiang; Lou, Ge*哈尔滨医科大学
Frontiers in Genetics2022-6-8DOI: 10.3389/fgene.2022.823082
2被引5阅读
引用收藏
分享

摘要

Ovarian cancer is one of the most common gynecological malignancies in women, with a poor prognosis and high mortality. With the expansion of single-cell RNA sequencing technologies, the inner biological mechanism involved in tumor recurrence should be explored at the single-cell level, and novel prognostic signatures derived from recurrence events were urgently identified. In this study, we identified recurrence-related genes for ovarian cancer by integrating two Gene Expression Omnibus datasets, including an ovarian cancer single-cell RNA sequencing dataset (GSE146026) and a bulk expression dataset (GSE44104). Based on these recurrence genes, we further utilized the merged expression dataset containing a total of 524 ovarian cancer samples to identify prognostic signatures and constructed a 13-gene risk model, named RMGS (recurrence marker gene signature). Based on the RMGS score, the samples were stratified into high-risk and low-risk groups, and these two groups displayed significant survival difference in two independent validation cohorts including The Cancer Genome Atlas (TCGA). Also, the RMGS score remained significantly independent in multivariate analysis after adjusting for clinical factors, including the tumor grade and stage. Furthermore, there existed close associations between the RMGS score and immune characterizations, including checkpoint inhibition, EMT signature, and T-cell infiltration. Finally, the associations between RMGS scores and molecular subtypes revealed that samples with mesenchymal subtypes displayed higher RMGS scores. In the meanwhile, the genomics characterization from these two risk groups was also identified. In conclusion, the recurrence-related RMGS model we identified could provide a new understanding of ovarian cancer prognosis at the single-cell level and offer a reference for therapy decisions for patient treatment.

学科与关键词

关键词
ovarian cancersingle-cell RNA-seqprognostic modelimmune subtypesrecurrence
相关
加载中…
  • Development and validation of an individualized gene expression-based signature to predict overall survival of patients with high-grade serous ovarian carcinoma
    Yuan, Dandan; Zhu, Hong; Wang, Ting; Zhang, Yang; Zheng, Xin; Qu, Yanjun*EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28(1): 465.
  • Single-cell RNA-seq recognized the initiator of epithelial ovarian cancer recurrence
    Kan, Tongtong*; Zhang, Shupeng; Zhou, Shengtao; Zhang, Ya; Zhao, Yun; Gao, Yinghua; Zhang, Tao; Gao, Feng; Wang, Xin; Zhao, Linjie; Yang, Mengsu*Oncogene, 2022, 41(6): 895-906.被引 18
  • Immunogenic cell death-related gene landscape predicts the overall survival and immune infiltration status of ovarian cancer
    Zhang, Wenwen; Liu, Tianbo; Jiang, Liangliang; Chen, Jiarong; Li, Qiuli; Wang, Jing*Frontiers in Genetics, 2022, 13: 1001239.被引 6
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Genetics
发表日期
2022-06-08
卷期
第 13 卷
页码
823082
DOI
10.3389/fgene.2022.823082
期刊等级
3区
成果收录
SCIE

作者

  • Z

    Zhang, Yongjian (第一作者)

    harbin med univ

  • H

    Huang, Wei

    harbin med univ

查看全部 7 位作者收起作者
  • C

    Chen, Dejia

    harbin med univ

  • Z

    Zhao, Yue

    harbin med univ

  • S

    Sun, Fusheng

    harbin med univ

  • W

    Wang, Zhiqiang

    harbin med univ

  • L

    Lou, Ge (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417